Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
ABT [NYSE]
Abbott Laboratories
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
IndexS&P 500 P/E74.67 EPS (ttm)0.49 Insider Own0.24% Shs Outstand1.56B Perf Week1.16%
Market Cap57.04B Forward P/E16.26 EPS next Y2.25 Insider Trans12.99% Shs Float1.56B Perf Month-0.79%
Income772.00M PEG6.35 EPS next Q0.44 Inst Own69.88% Short Float0.80% Perf Quarter4.69%
Sales21.59B P/S2.64 EPS this Y-87.94% Inst Trans3.13% Short Ratio1.69 Perf Half Y20.88%
Book/sh16.95 P/B2.16 EPS next Y11.94% ROA- Target Price39.94 Perf Year26.39%
Cash/sh- P/C- EPS next 5Y11.76% ROE- 52W Range27.82 - 37.70 Perf YTD17.61%
Dividend0.56 P/FCF- EPS past 5Y-30.92% ROI- 52W High-2.94% Beta0.36
Dividend %1.53% Quick Ratio- Sales past 5Y-3.67% Gross Margin55.16% 52W Low31.54% ATR0.62
Employees91000 Current Ratio- Sales Q/Q1.78% Oper. Margin2.18% RSI (14)53.03 Volatility1.82% 1.54%
OptionableYes Debt/Eq- EPS Q/Q55.38% Profit Margin3.58% Rel Volume0.95 Prev Close36.83
ShortableYes LT Debt/Eq- EarningsApr 17 BMO Payout- Avg Volume7.34M Price36.59
Recom2.60 SMA20-0.25% SMA502.10% SMA20010.86% Volume6,997,026 Change-0.65%
19-Apr-13Reiterated RBC Capital Mkts Outperform $37 → $38
18-Apr-13Reiterated Stifel Buy $40 → $44
12-Apr-13Reiterated Deutsche Bank Hold $33 → $35
15-Feb-13Initiated Stifel Nicolaus Buy $40
11-Jan-13Reiterated UBS Buy $75 → $38
11-Jan-13Initiated Barclays Equal Weight $35
04-Jan-13Downgrade Deutsche Bank Buy → Hold $70 → $33
19-Jul-12Reiterated UBS Buy $68 → $72
19-Mar-12Reiterated UBS Buy $62 → $68
19-Mar-12Reiterated RBC Capital Mkts Outperform $60 → $68
09-Dec-11Downgrade Barclays Capital Overweight → Equal Weight $55 → $55
27-Oct-11Reiterated Deutsche Bank Hold $53 → $58
24-Aug-11Downgrade Morgan Keegan Outperform → Mkt Perform $60 → $57
07-Apr-11Initiated Deutsche Bank Hold $53
24-Jan-11Reiterated Barclays Capital Overweight $60 → $55
18-Jan-11Downgrade RBC Capital Mkts Top Pick → Outperform $66 → $60
27-Oct-10Downgrade Argus Buy → Hold
12-Mar-10Downgrade Citigroup Hold → Sell $46 → $52
28-Jan-10Reiterated RBC Capital Mkts Top Pick $62 → $68
14-Jan-10Reiterated Barclays Capital Overweight $56 → $60
17-May-13 06:34PM  Abbott Laboratories Stock Checkup for May at Motley Fool
06:29PM  Jim Cramer's Down and Out Turnaround Play at CNBC
06:29PM  [video] Companies That Shine After Spinoffs at CNBC
06:02PM  Cramer: Break-Up Could Boost This Stock 19% at CNBC
16-May-13 07:15PM  [$$] AbbVie Is Good Medicine at Barrons.com
06:46PM  Here's What This Big Market-Beater Has Been Buying and Selling at Motley Fool
15-May-13 05:06PM  Googles Page Describes Speech Malady, Funds Research at Bloomberg
04:49PM  J&J Wins Expanded Approval of Simponi for Bowel Disease at Bloomberg
12:24PM  LabStyle Innovations - Glucose Monitoring For The Mobile Age at Seeking Alpha
11:51AM  Three Stocks that Offer Protection from Market Tantrums at Motley Fool
07:55AM  3 Pharmaceuticals For Attractive Dividends at Seeking Alpha
07:00AM  Zacks Analyst Say 'Buy' LabStyle Innovations Zacks Small Cap Research
12:01AM  Googles Page Describes Speech Malady, Funds Research at Bloomberg
14-May-13 05:00PM  Abbott Laboratories (ABT): Today's Featured Health Services Winner at TheStreet
01:04PM  ABBOTT LABORATORIES Financials EDGAR Online Financials
12:43PM  Cramer Says Buy Abbott Labs, Cedar Fair, and These 2 Stocks at Wall St. Cheat Sheet
12:24PM  Blue Ridge Capital betting big on a pharma stock at MarketWatch
07:04AM  Cramer's Lightning Round - Goodyear Is In The Wilderness (5/13/13) at Seeking Alpha
06:00AM  'Mad Money' Lightning Round: Valero Isn't What It Was at TheStreet
13-May-13 06:40PM  Lightning Round: Valero, Abbott Labs & More at CNBC
06:40PM  [video] Lightning Round at CNBC
01:03PM  5 Stocks Boosting The Health Services Industry Higher at TheStreet
12:20PM  Va. entrepreneur caught in growing political drama AP
11-May-13 02:01PM  Directors Disappoint by What They Dont Do at New York Times
11:05AM  Dont Make Investing Too Complicated at Motley Fool
10-May-13 08:54PM  5 Stocks Loved By This Oregon-Based Fund at Motley Fool
08:04PM  Abbvie says Chief Scientific Officer John Leonard to retire at Reuters
05:17PM  AbbVie Science Chief to Retire With No Successor in Place at Bloomberg
01:04PM  Marketers Seek Fix as Email Overwhelms Consumers Big Data Download
01:04PM  Marketers Seek Fix as Email Overwhelms Consumers
12:25PM  This New Drug Maker Still Has Upside Potential Left at Motley Fool
09-May-13 12:05PM  VolitionRx Could Be A Game Changer In Cancer Detection at Seeking Alpha
11:48AM  Drug Firms Find New Way to Shorten Clinical Trials Big Data Download
11:48AM  Drug Firms Find New Way to Shorten Clinical Trials
07:12AM  Obesity Drug Demand Still Low at Motley Fool
07:05AM  InPlay: Abbott Labs announces CE Mark for test to aid doctors with diagnosing and monitoring diabetes Briefing.com
07:00AM  Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes PR Newswire
08-May-13 01:38PM  The Ups and Downs of Diabetes at Motley Fool
08:30AM  Abbott to Present at UBS Global Healthcare Conference PR Newswire
07-May-13 01:09PM  Eating Up Dividends With Abbott Laboratories at Seeking Alpha
12:47PM  Imminent Catalysts For Small Pharmaceuticals at Seeking Alpha
12:16PM  Patient Investors Will Find The Right Prescription In Hospira at Forbes
12:07PM  REUTERS SUMMIT-Drug industry CEOs plotting more carve-outs at Reuters
09:01AM  Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy at Seeking Alpha
06-May-13 08:00PM  Today's 3 Worst Stocks at Motley Fool
05:01PM  Abbott Laboratories (ABT): Today's Featured Health Services Laggard at TheStreet
02:41PM  FDA warns pregnant women of migraine drug risk AP
02:16PM  Are These Spin-Offs Investment Worthy? at Motley Fool
02:07PM  FDA warns on use of certain migraine drugs during pregnancy at Reuters
04-May-13 09:08AM  Abbott Shifts Focus to Nutrition Demand Overseas at Motley Fool
03-May-13 06:00AM  The New Abbott Labs Is Leaner, but Needs Better Execution at TheStreet
02-May-13 03:47PM  China's Parents Crave Illegally Imported Baby Formula at BusinessWeek
08:52AM  Is Abbott a Good Defensive Play? at Wall St. Cheat Sheet
30-Apr-13 11:38PM  At These Levels, Covidien Has Room To Run at Seeking Alpha
06:06PM  Abbott Laboratories Stock Is Half What It Used to Be at Motley Fool
05:27PM  Apple prices $17 bln bond deal to strong demand at MarketWatch
04:50PM  Building a Stronger Core With Abbott Laboratories at Motley Fool
04:46PM  Zoetis Beats, Pfizer Misses In Dual Q1 Reports at Investor's Business Daily
04:03PM  [$$] Pfizer Still an Easy Pill to Swallow at Barrons.com
02:15PM  Apple launches $17 bln bond deal at MarketWatch
01:31PM  Apple sees high demand for bond offering at MarketWatch
01:22PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
12:52PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
12:24PM  [$$] Sale of Brazil Drug Maker Stalls at The Wall Street Journal
11:50AM  [$$] Auction of Brazil Drug Maker Stalls at The Wall Street Journal
11:47AM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
11:33AM  The Foundations of the Pharmaceutical Industry at Motley Fool
08:11AM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
04:25AM  Not All Dividend Increases Are The Same: 2 Dividend Trends That Can Make A Difference at Seeking Alpha
29-Apr-13 10:36PM  UPDATE 2-U.S. task force calls for routine HIV testing for all adults at Reuters
05:39PM  UPDATE 1-Task force calls for routine HIV testing for all adults at Reuters
04:16PM  You Dont Have to Run a Cartel to Make Big Profits in Drugs at Motley Fool
01:14PM  'Ultimate' Stock Picker's Favorite Names at CNBC
01:03PM  5 Drugs Stocks Nudging The Industry Higher at TheStreet
12:09PM  [video] Top Stock Picker's Favorite Names at CNBC
11:16AM  Diabetes Isn't Good for Health, But It Can Be for Your Portfolio at Motley Fool
10:12AM  ABBOTT LABORATORIES Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
28-Apr-13 07:00PM  Could Enzo Biochem's Intellectual Property Lawsuits Be Worth Billions? at Seeking Alpha
09:38AM  Can This New Drug Win Against Established Competitors? at Motley Fool
09:08AM  When Others Are Fearful: Danone and Europe at Motley Fool
05:51AM  Abbott Is A Solid Long-Term Investment at Seeking Alpha
27-Apr-13 06:36PM  Blame Obamacare for the Medical-Device Sales Slump? at Motley Fool
05:34PM  Mead Johnson Nutrition Needs A New Formula For China at Seeking Alpha
03:06PM  AbbVie Q1: Story of Humira and the 7 Dwarfs at Motley Fool
26-Apr-13 04:10PM  AbbVie Profit Beats Analysts Estimates in First Quarter at Bloomberg
03:20PM  Earnings Beat for ABAX, Sluggish Overall Zacks
03:11PM  10 JPMorgan New Sovereign Dogs Bare 5.2% To 39.3% Net Gains In April at Seeking Alpha
01:13PM  AbbVie 1Q earnings top analyst estimates AP
01:01PM  UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug at Reuters
12:48PM  Aggressive Movement in HCV Drug Development Heightens FDA Focus on Safety: Expert Analyst David Ferreiro Discusses Regulatory Challenges in the Pharmaceutical Space Wall Street Transcript
11:25AM  AbbVie Beats Q1 Estimates As Rival Pfizer Takes Hit at Investor's Business Daily
09:54AM  Humira Still Abbvie Story With Pipeline Chapter Ahead at Forbes
09:54AM  Abbvie Still Rolls With Humira While Drug Pipeline Develops at Forbes
08:15AM  UPDATE 1-AbbVie meets expectations, fueled by Humira sales at Reuters
08:04AM  AbbVie Profit Beats Analysts Estimates in First Quarter at Bloomberg
08:01AM  AbbVie meets expectations, fueled by Humira sales at Reuters
25-Apr-13 05:57PM  Pfizers Arthritis Drug Rejected by European Regulators at Bloomberg
02:58PM  Which One Should Investors Buy: The Ex-Parent or the Spin-off? at Motley Fool
10:44AM  The Key Earnings Details of the Medical Device Industry at Motley Fool
24-Apr-13 06:20PM  How Will AbbVie's Earnings Fare? at Motley Fool
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FREYMAN THOMAS CExecutive Vice PresidentApr 01Option Exercise22.2763,8001,420,635358,713Apr 03 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 12Option Exercise25.5349,5641,265,313337,400Mar 14 05:10 PM
Warmuth Michael JExecutive Vice PresidentFeb 19Sale34.783,066106,64135,552Feb 20 06:19 PM
Mason Heather LSenior Vice PresidentFeb 19Sale34.793,066106,672194,172Feb 20 06:18 PM
Simhambhatla Murthy VSenior Vice PresidentFeb 19Sale34.7840213,98331,135Feb 20 06:18 PM
LINDER GREG WDirectorFeb 19Sale34.761,31445,679146,663Feb 20 05:35 PM
Landgraf John CExecutive Vice PresidentFeb 19Sale34.783,066106,641118,492Feb 20 05:34 PM
Fussell Stephen RSenior Vice PresidentFeb 19Sale34.803,066106,702112,558Feb 20 05:32 PM
Blaser Brian JExecutive Vice PresidentFeb 19Sale34.791,02235,558108,137Feb 20 05:18 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 19Sale34.794,672162,545354,149Feb 20 05:18 PM
Fussell Stephen RSenior Vice PresidentFeb 01Option Exercise31.909,690309,123104,783Feb 04 05:56 PM
OSBORN WILLIAM ADirectorFeb 01Buy33.8610,000338,55834,476Feb 04 05:55 PM
Fussell Stephen RSenior Vice PresidentFeb 01Sale33.899,690328,39495,093Feb 04 05:56 PM
WHITE MILES DChairman and CEOJan 14Option Exercise25.76346,7048,929,5351,569,971Jan 16 05:04 PM
Schumacher Laura JExecutive Vice PresidentDec 11Option Exercise50.14119,7776,006,037299,115Dec 13 05:14 PM
Schumacher Laura JExecutive Vice PresidentDec 11Sale66.00119,7777,905,282179,338Dec 13 05:14 PM
Forrest A. DavidSenior Vice PresidentDec 10Option Exercise50.5235,3351,785,20170,350Dec 12 05:12 PM
Forrest A. DavidSenior Vice PresidentDec 10Sale65.1047,2863,078,31923,064Dec 12 05:12 PM
Blaser Brian JExecutive Vice PresidentDec 06Option Exercise50.5264,1013,238,564143,825Dec 10 05:04 PM
Blaser Brian JExecutive Vice PresidentDec 06Sale64.5226,3541,700,36079,724Dec 10 05:05 PM
Blaser Brian JExecutive Vice PresidentDec 06Sale64.4537,7472,432,931106,078Dec 10 05:04 PM
Forrest A. DavidSenior Vice PresidentDec 06Sale64.5935222,73622,755Dec 21 02:45 PM
WHITE MILES DChairman and CEONov 02Option Exercise54.05513,31227,743,2731,753,068Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.62122,4318,033,8601,256,913Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.7917,1571,128,7601,239,756Nov 05 06:02 PM
WHITE MILES DChairman and CEONov 02Sale65.52373,72424,487,7961,379,344Nov 05 06:02 PM
Blaser Brian JExecutive Vice PresidentOct 25Sale65.764,000263,04279,724Oct 26 05:04 PM
Fussell Stephen RSenior Vice PresidentOct 24Option Exercise60.395,948359,200103,041Oct 26 05:04 PM
Fussell Stephen RSenior Vice PresidentOct 24Sale66.007,948524,56895,093Oct 26 05:04 PM
ALBAN CARLOSSenior Vice PresidentSep 25Option Exercise57.251,19868,586116,015Sep 27 05:10 PM
ALBAN CARLOSSenior Vice PresidentSep 25Sale70.001,19883,860114,817Sep 27 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentSep 21Option Exercise44.1630,0001,324,800438,086Sep 25 05:05 PM
ALBAN CARLOSSenior Vice PresidentSep 20Option Exercise56.981,918109,288116,735Sep 21 05:09 PM
ALBAN CARLOSSenior Vice PresidentSep 20Sale69.751,918133,781114,817Sep 21 05:09 PM
LINDER GREG WVice PresidentSep 14Option Exercise54.741,839100,667131,902Sep 17 05:04 PM
Warmuth Michael JSenior Vice PresidentSep 13Option Exercise54.053,368182,04047,993Sep 17 05:05 PM
ALBAN CARLOSSenior Vice PresidentSep 13Option Exercise56.001,33174,536116,148Sep 17 05:06 PM
ALBAN CARLOSSenior Vice PresidentSep 13Sale68.751,33191,506114,817Sep 17 05:06 PM
Landgraf John CExecutive Vice PresidentSep 07Option Exercise53.1838,5652,050,778132,777Sep 11 05:13 PM
Landgraf John CExecutive Vice PresidentAug 31Option Exercise49.13140,2586,891,194231,403Sep 05 05:16 PM
Landgraf John CExecutive Vice PresidentAug 31Sale65.50130,9448,576,83294,212Sep 05 05:16 PM
Warmuth Michael JSenior Vice PresidentAug 16Option Exercise44.169,400415,10454,025Aug 17 05:10 PM
Warmuth Michael JSenior Vice PresidentAug 16Sale66.479,400624,85444,625Aug 17 05:10 PM
Mason Heather LSenior Vice PresidentAug 01Option Exercise47.1396,3094,538,584228,121Aug 03 05:12 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.328,700576,979124,312Aug 03 05:11 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.2649,7963,299,638133,012Aug 03 05:12 PM
Mason Heather LSenior Vice PresidentAug 01Sale66.1945,3132,999,371182,808Aug 03 05:12 PM
Warmuth Michael JSenior Vice PresidentJul 30Option Exercise52.236,274327,69150,029Aug 01 05:28 PM
LINDER GREG WVice PresidentJul 30Option Exercise52.5320,5561,079,884148,106Aug 01 05:27 PM
Schumacher Laura JExecutive Vice PresidentJul 30Option Exercise52.744,560240,494152,594Aug 01 05:26 PM
Fussell Stephen RSenior Vice PresidentJul 30Option Exercise53.0010,988582,364106,783Aug 01 05:24 PM
ALBAN CARLOSSenior Vice PresidentJul 27Option Exercise43.1144,8371,933,087160,006Jul 30 05:05 PM
ALBAN CARLOSSenior Vice PresidentJul 27Sale65.0344,8372,915,943115,169Jul 30 05:05 PM
ALBAN CARLOSSenior Vice PresidentJul 23Option Exercise48.925,435265,858119,503Jul 25 05:39 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 23Option Exercise44.1630,0001,324,800432,443Jul 25 05:30 PM
Warmuth Michael JSenior Vice PresidentJul 23Option Exercise51.913,572185,42346,858Jul 25 05:08 PM
Fussell Stephen RSenior Vice PresidentJun 29Option Exercise50.952,275115,91198,070Jul 03 05:18 PM
Fussell Stephen RSenior Vice PresidentJun 29Sale64.422,275146,55895,795Jul 03 05:18 PM
Schumacher Laura JExecutive Vice PresidentJun 19Option Exercise50.037,455372,974154,607Jun 20 05:16 PM
Schumacher Laura JExecutive Vice PresidentJun 18Option Exercise44.6156,0892,501,919202,163Jun 20 05:14 PM
Schumacher Laura JExecutive Vice PresidentJun 18Sale62.7323,5001,474,106147,152Jun 20 05:16 PM
Schumacher Laura JExecutive Vice PresidentJun 18Sale62.6226,3001,646,794170,652Jun 20 05:14 PM
Fussell Stephen RSenior Vice PresidentJun 01Sale61.216,000367,26295,795Jun 04 05:10 PM
open in yahoo | open in reuters | open in google